<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JCN</journal-id>
<journal-id journal-id-type="hwp">spjcn</journal-id>
<journal-id journal-id-type="nlm-ta">J Child Neurol</journal-id>
<journal-title>Journal of Child Neurology</journal-title>
<issn pub-type="ppub">0883-0738</issn>
<issn pub-type="epub">1708-8283</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0883073812458712</article-id>
<article-id pub-id-type="publisher-id">10.1177_0883073812458712</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Correspondence</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Reduced Retinal Nerve Fiber Layer Thickness and Macular Volume in Pediatric Multiple Sclerosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Gundogan</surname>
<given-names>Fatih Cakir</given-names>
</name>
<xref ref-type="aff" rid="aff1-0883073812458712">1</xref>
<xref ref-type="corresp" rid="corresp1-0883073812458712"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Colakoglu</surname>
<given-names>Kadir</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0883073812458712">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yucel</surname>
<given-names>Mehmet</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0883073812458712">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-0883073812458712">
<label>1</label>Etimesgut Military Hospital, Ophthalmology, Ankara, Turkey</aff>
<aff id="aff2-0883073812458712">
<label>2</label>Kasimpasa Military Hospital, Ophthalmology, Istanbul, Turkey</aff>
<aff id="aff3-0883073812458712">
<label>3</label>Kasimpasa Military Hospital, Neurology, Istanbul, Turkey </aff>
<author-notes>
<corresp id="corresp1-0883073812458712">Fatih Cakir Gundogan, Etimesgut Asker Hastanesi Ankara, 06790 Turkey Email: <email>fgundogan@yahoo.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>12</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>12</issue>
<fpage>1620</fpage>
<lpage>1620</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>We congratulate Yilmaz et al<sup><xref ref-type="bibr" rid="bibr1-0883073812458712">1</xref></sup> for their study investigating the retinal nerve fiber layer thickness and pattern visual evoked potential changes in a pediatric population with multiple sclerosis. This subject area was in fact investigated in a large amount of studies; however, the study is important for having included pediatric participants.<sup><xref ref-type="bibr" rid="bibr1-0883073812458712">1</xref></sup>
</p>
<p>As the authors stated, the study explored some conflicting results about retinal nerve fiber layer thickness and pattern visual evoked potential changes. The authors found that mean retinal nerve fiber layer thickness was reduced significantly in eyes of patients without optic neuritis and affected eyes of patients with optic neuritis, and insignificantly in unaffected eyes of patients with optic neuritis. Mean and all 4 quadrants’ retinal nerve fiber layer thickness and macular volume were found to be decreased significantly in eyes with time interval from clinical optic neuritis longer than 6 months. The authors also found no significant difference in pattern visual evoked potential between affected and unaffected eyes of patients with previous optic neuritis.</p>
<p>It is hypothesized that multiple sclerosis is a <italic>chronic progressive</italic> neurodegenerative disease with acute exacerbations. Pattern visual evoked potential amplitude reductions and latency increases in patients without clinical signs and symptoms supports this theory. Also we know that the visual acuities of patients with multiple sclerosis are sometimes found to be less than normal in routine ophthalmologic examinations. The fluctuations in visual acuity in these patients also support the subclinical involvement in multiple sclerosis. In a recent study,<sup><xref ref-type="bibr" rid="bibr2-0883073812458712">2</xref></sup> we found increased latencies and decreased amplitudes in a group of patients with a full visual acuity and without a history of clinical signs of optic neuropathy in the past. From this point of view, it is probably the best approach to stratify multiple sclerosis patients with respect to pattern visual evoked potential changes, not clinical signs and symptoms. The pattern visual evoked potential findings of Yilmaz et al<sup><xref ref-type="bibr" rid="bibr1-0883073812458712">1</xref></sup> also support this approach.</p>
<p>The retinal nerve fiber layer thickness reduction is mostly caused by secondary retrograde degeneration of the nerve fibers. For this reason, time interval is required to cause the retinal nerve fiber layer thickness reduction after optic neuritis. The authors stated that the time interval between clinical optic neuritis and the inclusion in the study ranged from 3 months to 32 months. Short time interval may not be enough to cause retinal nerve fiber layer reduction.</p>
<p>The number of the participants is small. Stratifying the group further lessens the number and makes the statistics more unreliable. Because of these reasons, we kindly ask the authors to determine (1) the correlations between retinal nerve fiber layer thickness/macular volume and P100 amplitude/latency changes and (2) the correlations between time interval and P100 amplitude/latency and retinal nerve fiber layer thickness/macular volume <italic>by including all patient and control eyes.</italic> The results of these new statistics will not only explore the subclinical characteristics of the multiple sclerosis group in the study but also give us the opportunity to examine the above-mentioned theory.</p>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-0883073812458712">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yilmaz</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Gücüyener</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Erin</surname>
<given-names>DM</given-names>
</name>
<etal/>
</person-group>. <article-title>Reduced retinal nerve fiber layer thickness and macular volume in pediatric multiple sclerosis</article-title>. <source>J Child Neurol</source>. <year>2012</year>. <comment>doi:10.1177/0883073812447683</comment>
</citation>
</ref>
<ref id="bibr2-0883073812458712">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gundogan</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Demirkaya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sobaci</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Is optical coherence tomography really a new biomarker candidate in multiple sclerosis? A structural and functional evaluation</article-title>. <source>Invest Ophthalmol Vis Sci</source>. <year>2007</year>;<volume>48</volume>:<fpage>5773</fpage>–<lpage>5781</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>